glutathione energy boost Immunity Duo Boost Your Health with Powerful

Adv Opt Mater, 2020, 8: 1901911 Yang L, Su N, Huang J, et al

Features Nano-Glutathione technology, with active ingredients 6,024x smaller than pores for fast, deep absorption

Why this trial matters : First oral SERD to succeed in Phase III in early breast cancer Signals a potential new adjuvant standard of care Advances endocrine therapy beyond legacy agents Johnson & Johnson Tecvayli + Darzalex Faspro Shows Unprecedented Phase III Success in Relapsed/Refractory Multiple Myeloma The Phase III MajesTEC-3 trial demonstrated that the combination of Tecvayli (teclistamab) plus Darzalex Faspro (daratumumab SC) significantly improved progression-free survival and overall survival versus standard regimens in patients with relapsed/refractory multiple myeloma as early as second-line, with an ~83% reduction in disease progression or death at almost three years follow-up

The combined logic is: Three receptor pathways at once